Metraipolis › archive › dc_a453aa29fece

Targeting pancreatic cancer with natural compounds: molecular mechanisms, preclinical evidence, clinical perspectives, and limitations — Europe PMC PMID:42755980

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42755980
DOI
10.3389/fphar.2026.1868595
License (as archived)
solo-consultazione
Archived
2026-10-16T04:39:56.796Z
SHA-256 of the archived text
e99285754ec4ffe73cdcc6c0c8ab2cabbdab49b4cbaccd8fd36564053084480f
Stable URL of this page
https://metraipolis.com/documento/dc_a453aa29fece

How to cite

Targeting pancreatic cancer with natural compounds: molecular mechanisms, preclinical evidence, clinical perspectives, and limitations — Europe PMC PMID:42755980 — Europe PMC (en), https://europepmc.org/article/MED/42755980 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a453aa29fece (Metraipolis archive dc_a453aa29fece, sha256 e99285754ec4ffe73cdcc6c0c8ab2cabbdab49b4cbaccd8fd36564053084480f)
BibTeX
@misc{dca453aa29fece,
  title = {Targeting pancreatic cancer with natural compounds: molecular mechanisms, preclinical evidence, clinical perspectives, and limitations — Europe PMC PMID:42755980},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42755980},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a453aa29fece; sha256 e99285754ec4ffe73cdcc6c0c8ab2cabbdab49b4cbaccd8fd36564053084480f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42755980. Agents can read the archived copy with the MCP tool read_document.